Sequence and Time-of-day Infusion of immunoCHemotherapy Affect Response in Oesophageal Cancer in the NeOadjuvant Setting
NCT05615129
·
clinicaltrials.gov ↗
COMPLETED
Status
350
Enrollment
OTHER
Sponsor class
Conditions
Esophagus Cancer
Sponsor
Guangdong Provincial People's Hospital
Collaborators
[object Object]
[object Object]